Rhythm Control Strategies for Atrial Flutter

Acute Rhythm Control Options

The American Heart Association recommends oral dofetilide or intravenous ibutilide as first-line agents for acute pharmacological cardioversion of atrial flutter in patients with symptomatic atrial flutter or those refractory to pharmacological rate control 1, 2
Flecainide and propafenone can be used for acute cardioversion in patients without structural heart disease, with a caution for potential 1:1 AV conduction in atrial flutter 3
Elective synchronized cardioversion is indicated for stable patients with well-tolerated atrial flutter when pursuing rhythm control, with immediate synchronized cardioversion recommended for hemodynamically unstable patients who don't respond to pharmacological therapies 1, 4, 5
Atrial flutter typically requires lower energy levels for successful cardioversion compared to atrial fibrillation 5
Rapid atrial pacing is useful for acute conversion in patients with pacing wires in place, particularly beneficial when sedation is contraindicated or in cases of digitalis toxicity 1, 2, 5

Catheter ablation of the cavotricuspid isthmus (CTI) is the most effective rhythm control strategy for patients with symptomatic atrial flutter or those refractory to pharmacological rate control, with success rates exceeding 90% and low complication rates 1, 2
The American College of Cardiology recommends CTI ablation as first-line therapy for CTI-dependent atrial flutter that is symptomatic or refractory to pharmacological rate control 1, 2
CTI ablation is reasonable for patients with recurrent symptomatic non-CTI-dependent flutter as primary therapy before antiarrhythmic drug trials, and should be considered in patients undergoing AF ablation who have documented or induced CTI-dependent flutter 1, 2

The risk of developing atrial fibrillation after CTI ablation for atrial flutter is 22-50% within 14-30 months, with risk factors including prior AF, depressed left ventricular function, structural heart disease, inducible AF, and increased left atrial size 1, 2
Anticoagulation recommendations for atrial flutter align with those for atrial fibrillation, with anticoagulation for at least 3 weeks before and 4 weeks after cardioversion for flutter ≥48 hours or unknown duration 1, 4, 5, 6